Pharmacokinetics and pharmacodynamics of LC15-0444, a novel DPP IV inhibitor, after single oral administration in healthy subjects.

被引：0

作者：

Choi, Y. J. ^{[1
]}

Lim, K. S. ^{[1
]}

Kim, K. P. ^{[1
]}

Cho, J. Y. ^{[1
]}

Yu, K. S. ^{[1
]}

Shin, S. G. ^{[1
]}

Yim, H. J.

Kwon, O. H. ^{[2
]}

Lee, J. I. ^{[2
]}

Kim, D. K. ^{[3
]}

Jang, I. J. ^{[1
]}

机构：

[1] Seoul Natl Univ, Coll Med & Hosp, Seoul, South Korea

[2] LG Life Sci Ltd, Res & Dev Pk, Taejon, South Korea

[3] LG Life Sci Ltd, Clin Dev, Taejon, South Korea

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S88 / S88

页数：1

共 50 条

[1] Pharmacokinetic and pharmacodynamic profiles of LC15-0444, a novel DPP IV inhibitor, after multiple oral administration in healthy subjects.
Shin, K. H.
Lim, K. S.
Kim, K. P.
Cho, J. Y.
Yu, K. S.
Shin, S. G.
Yim, H. J.
Kwon, O. H.
Lee, J.
Kim, D. K.
Jang, I. J.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S95 - S96
[2] Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers
Lim, Kyoung Soo
Cho, Joo-Youn
Kim, Bo-Hyung
Kim, Jung-Ryul
Kim, Hwa-Sook
Kim, Dong-Kyu
Kim, Sung-Ho
Yim, Hyeon Joo
Lee, Sung-Hack
Shin, Sang-Goo
Jang, In-Jin
Yu, Kyung-Sang
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (06) : 883 - 890
[3] Safety, tolerability, pharmacokinetics, & pharmacodynarnics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, in healthy male subjects: Multiple ascending dose study
Kim, Dong-Kyu
Lim, Kyoung Soo
Cho, Joo-Youn
Yu, Kyung-Sang
Shin, Sang-Goo
Kim, Sung-Ho
Hwang, Dal-Mi
Kwon, O. Hwan
Lee, Sung-Hack
Lee, Jaeick
Kim, Jeong-Ae
Jang, In-Jin
Yim, Hyeon Joo
[J]. DIABETES, 2008, 57 : A588 - A588
[4] LC15-0444 is a novel, potent, selective, and orally active dipeptidyl peptidase IV inhibitor
Hwang, Dal-Ml
Kim, Sung-Ho
Yoon, Min-Kyung
Kwon, O. Hwan
Goo, Kidong
Min, Changhee
Lee, Sung-Hack
Lee, Jaeick
Lee, Chang-Seok
Yim, Hyeon Joo
[J]. DIABETES, 2008, 57 : A150 - A150
[5] Evaluation of the pharmacokinetic interaction between the dipeptidyl peptidase IV inhibitor LC15-0444 and pioglitazone in healthy volunteers
Kim, Sung Eun
Yi, SoJeong
Shin, Kwang-Hee
Kim, Tae-Eun
Kim, Min-Jeong
Kim, Youn Hoa
Yoon, Seo Hyun
Cho, Joo-Youn
Shin, Sang-Goo
Jang, In-Jin
Yu, Kyung-Sang
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2012, 50 (01) : 17 - 23
[6] PHARMACOKINETICS AND PHARMACODYNAMICS OF IV AND ORAL FORMULATIONS OF CG-745 AFTER A SINGLE ADMINISTRATION IN HEALTHY KOREAN SUBJECTS
Kim, B.
Bae, S.
Park, S.
Jang, I
Oh, J.
Cho, S.
Kim, Y.
Lee, S.
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S35 - S35
[7] POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF SALMON CALCITONIN AFTER ORAL ADMINISTRATION OF SMC021 IN HEALTHY SUBJECTS.
Chigutsa, E.
Ngaimisi-Kitabi, E.
Sunkara, G.
Choi, L.
Bouillon, T.
Jiang, X.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S125 - S125
[8] Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects.
Hassan-Alin, M
Rohss, K
Andersson, T
Nyman, L
[J]. GASTROENTEROLOGY, 2000, 118 (04) : A16 - A16
[9] The pharmacokinetics and pharmacodynamics of PF-00734200, a DPP-IV inhibitor, in healthy Japanese subjects
Muto, Chieko
Dai, Haiqing
Teeter, John G.
Johnson, Susan
Cropp, Anne B.
Chiba, Koji
Suwa, Toshio
[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2012, 50 (07) : 505 - 509
[10] Pharmacokinetics and Pharmacodynamics of PF-734200, a DPP-IV Inhibitor, in Healthy Japanese Subjects
Dai, Haiqing
Johnson, Susan L.
Muto, Chieko
Banerjee, Subhashis
Yachi, Yasunori
Nguyen, Tu T.
Ghazzi, Mahmoud
[J]. DIABETES, 2009, 58 : A534 - A534

← 1 2 3 4 5 →